A citation-based method for searching scientific literature


List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Negative affective states and cognitive impairments in nicotine dependence.
F Scott Hall, Andre Der-Avakian, Thomas J Gould, Athina Markou, Mohammed Shoaib, Jared W Young. Neurosci Biobehav Rev 2015
42
33

Input-specific control of reward and aversion in the ventral tegmental area.
Stephan Lammel, Byung Kook Lim, Chen Ran, Kee Wui Huang, Michael J Betley, Kay M Tye, Karl Deisseroth, Robert C Malenka. Nature 2012
761
33

Effect of nicotine and nicotinic receptors on anxiety and depression.
Marina R Picciotto, Darlene H Brunzell, Barbara J Caldarone. Neuroreport 2002
301
33

Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons.
Dipesh Chaudhury, Jessica J Walsh, Allyson K Friedman, Barbara Juarez, Stacy M Ku, Ja Wook Koo, Deveroux Ferguson, Hsing-Chen Tsai, Lisa Pomeranz, Daniel J Christoffel,[...]. Nature 2013
578
33

Molecular Mechanisms Associated with Nicotine Pharmacology and Dependence.
Christie D Fowler, Jill R Turner, M Imad Damaj. Handb Exp Pharmacol 2020
4
33

Nicotine inhibits the VTA-to-amygdala dopamine pathway to promote anxiety.
Claire Nguyen, Sarah Mondoloni, Tinaïg Le Borgne, Ines Centeno, Maxime Come, Joachim Jehl, Clément Solié, Lauren M Reynolds, Romain Durand-de Cuttoli, Stefania Tolu,[...]. Neuron 2021
2
50

Converging vulnerability factors for compulsive food and drug use.
Katherine M Serafine, Laura E O'Dell, Eric P Zorrilla. Neuropharmacology 2021
1
100

Covid-19 interface with drug misuse and substance use disorders.
I E Cisneros, K A Cunningham. Neuropharmacology 2021
1
100


The role of gut-immune-brain signaling in substance use disorders.
Kelsey E Lucerne, Drew D Kiraly. Int Rev Neurobiol 2021
2
50

Promising vulnerability markers of substance use and misuse: A review of human neurobehavioral studies.
Briana Lees, Alexis M Garcia, Jennifer Debenham, Anna E Kirkland, Brittany E Bryant, Louise Mewton, Lindsay M Squeglia. Neuropharmacology 2021
2
50

Factors mediating pain-related risk for opioid use disorder.
Arbi Nazarian, S Stevens Negus, Thomas J Martin. Neuropharmacology 2021
4
33

Linking the CHRNA5 SNP to drug abuse liability: From circuitry to cellular mechanisms.
Julia K Brynildsen, Julie A Blendy. Neuropharmacology 2021
1
100

Addiction and the brain antireward system.
George F Koob, Michel Le Moal. Annu Rev Psychol 2008
726
33

Impulsivity traits and neurocognitive mechanisms conferring vulnerability to substance use disorders.
Antonio Verdejo-Garcia, Natalia Albein-Urios. Neuropharmacology 2021
6
33

Obesity and addiction: neurobiological overlaps.
N D Volkow, G-J Wang, D Tomasi, R D Baler. Obes Rev 2013
412
33

Neuroepigenetics and addiction.
Deena M Walker, Eric J Nestler. Handb Clin Neurol 2018
40
33

Precision Psychiatry and Dual Disorders.
Nestor Szerman, Lola Peris. J Dual Diagn 2018
9
33


Sex differences in progestogen- and androgen-derived neurosteroids in vulnerability to alcohol and stress-related disorders.
MacKenzie R Peltier, Terril L Verplaetse, Yann S Mineur, Ralitza Gueorguieva, Ismene Petrakis, Kelly P Cosgrove, Marina R Picciotto, Sherry A McKee. Neuropharmacology 2021
1
100

Social vulnerabilities for substance use: Stressors, socially toxic environments, and discrimination and racism.
Hortensia Amaro, Mariana Sanchez, Tara Bautista, Robynn Cox. Neuropharmacology 2021
2
50


Adolescent Substance Use Disorder Treatment: an Update on Evidence-Based Strategies.
Matthew C Fadus, Lindsay M Squeglia, Emilio A Valadez, Rachel L Tomko, Brittany E Bryant, Kevin M Gray. Curr Psychiatry Rep 2019
4
33

Does physical activity protect against drug abuse vulnerability?
Michael T Bardo, Wilson M Compton. Drug Alcohol Depend 2015
41
33

Sex differences in vulnerability to addiction.
Jacqueline A Quigley, Molly K Logsdon, Christopher A Turner, Ivette L Gonzalez, N B Leonardo, Jill B Becker. Neuropharmacology 2021
9
33


Sex-driven vulnerability in stress and drug abuse.
Alessandra Berry, Carla Raggi, Marta Borgi, Francesca Cirulli. Ann Ist Super Sanita 2016
5
33


Effect of early life social adversity on drug abuse vulnerability: Focus on corticotropin-releasing factor and oxytocin.
Michael T Bardo, Lindsey R Hammerslag, Samantha G Malone. Neuropharmacology 2021
1
100


Genetically selected alcohol-preferring msP rats to study alcohol use disorder: Anything lost in translation?
Anna Maria Borruto, Serena Stopponi, Hongwu Li, Friedbert Weiss, Marisa Roberto, Roberto Ciccocioppo. Neuropharmacology 2021
5
33

Sex Differences in Animal Models: Focus on Addiction.
Jill B Becker, George F Koob. Pharmacol Rev 2016
302
33

Neurobiological mechanisms of early life adversity, blunted stress reactivity and risk for addiction.
Mustafa al'Absi, Annie T Ginty, William R Lovallo. Neuropharmacology 2021
3
33

Addiction as a Coping Response: Hyperkatifeia, Deaths of Despair, and COVID-19.
George F Koob, Patricia Powell, Aaron White. Am J Psychiatry 2020
17
33

Drug Addiction: Updating Actions to Habits to Compulsions Ten Years On.
Barry J Everitt, Trevor W Robbins. Annu Rev Psychol 2016
422
33

Vulnerability to addiction.
R Maldonado, P Calvé, A García-Blanco, L Domingo-Rodriguez, E Senabre, E Martín-García. Neuropharmacology 2021
1
100

The emergence of insulin resistance following a chronic high-fat diet regimen coincides with an increase in the reinforcing effects of nicotine in a sex-dependent manner.
Bryan Cruz, Sebastian Ortegon, Priscilla Giner, Felix Matos-Ocasio, Andrea Rodriguez-Crespo, Kevin P Uribe, Kayla I Galindo, Katherine M Serafine, Arbi Nazarian, Laura E O'Dell. Neuropharmacology 2021
1
100

The relevance of reward pathways for schizophrenia.
Hisham Ziauddeen, Graham K Murray. Curr Opin Psychiatry 2010
64
33



Tobacco and alcohol use during adolescence: Interactive mechanisms in animal models.
Yael Abreu-Villaça, Alex C Manhães, Thomas E Krahe, Claudio C Filgueiras, Anderson Ribeiro-Carvalho. Biochem Pharmacol 2017
11
33

Behavioral, Biochemical, and Molecular Indices of Stress are Enhanced in Female Versus Male Rats Experiencing Nicotine Withdrawal.
Oscar V Torres, Luciana G Gentil, Luis A Natividad, Luis M Carcoba, Laura E O'Dell. Front Psychiatry 2013
45
33

Notes from the Field: Use of Electronic Cigarettes and Any Tobacco Product Among Middle and High School Students - United States, 2011-2018.
Karen A Cullen, Bridget K Ambrose, Andrea S Gentzke, Benjamin J Apelberg, Ahmed Jamal, Brian A King. MMWR Morb Mortal Wkly Rep 2018
377
33

Estrogens and the cognitive symptoms of schizophrenia: Possible neuroprotective mechanisms.
Claire McGregor, Alexander Riordan, Janice Thornton. Front Neuroendocrinol 2017
33
33


Chronic agmatine treatment prevents behavioral manifestations of nicotine withdrawal in mice.
Nandkishor R Kotagale, Chandrabhan T Chopde, Milind J Umekar, Brijesh G Taksande. Eur J Pharmacol 2015
24
33


Discovery and development of varenicline for smoking cessation.
Chloe J Jordan, Zheng-Xiong Xi. Expert Opin Drug Discov 2018
21
33

Presynaptic nicotinic ACh receptors.
S Wonnacott. Trends Neurosci 1997
33



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.